Can the effects of antidepressants be observed in the first two weeks of treatment? (multiple letters) [1]

Neuropsychopharmacology

Volumn 17, Issue 2, 1997, Pages 110-112

  Katz, M M ^a   Bowden, C ^a   Stokes, P ^a   Casper, R ^a   Frazer, A ^a   Koslow, S H ^a   Koscis, J ^a   Secunda, S ^a   Swann, A ^a   Berman, N ^a   Quintkin, F M ^a   McGrath, P J ^a   Stewart, J W ^a   Taylor, B P ^a   Klein, D F ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; IMIPRAMINE; MIRTAZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

BEHAVIOR; CLINICAL TRIAL; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LETTER; METHODOLOGY; PRIORITY JOURNAL;

EID: 0030742662     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00038-9     Document Type: Letter

References (17)

1. Casper RC Katz MM Bowden CL Davis JM Koslow SH Hanin I The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine J Affect Disord 31 1994 151 164
2. Cohen J Statistical Power Analysis for the Behavioral Sciences 1969 Academic Press New York
3. suppl DiMascio A Meyer RE Stifler L Effects of imipramine on individuals varying in level of depression Amer J Psychiatry 8 1968 55 58
4. Dunbar GC Cohn JB Fabre LF Feighner JP Fievre RR Mendels J Shrivastava RK A comparison of par-oxetine, imipramine and placebo in depressed outpa-tients Br J Psychiatry 159 1991 394 398
5. Frazer A Antidepressant drugs Depression 2 1994 1 19
6. Katz MM Koslow SH Frazer A Onset of antidepres-sant action: Reexamining the structure of depression and multiple drug actions Depression and Anxiety 4 1997 257 267
7. Katz MM Koslow SH Maas JW Frazer A Bowden CL Casper R Croughan J Kocsis J Redmond E The timing, specificity and clinical prediction of tricyclic drug effects in depression Psychol Med 17 1987 297 309
8. Katz MM Koslow SH Maas JW Frazer A Kocsis J Secunda S Bowden CL Casper R Identifying the specific clinical actions of amitriptyline: Interrelationships of behavior, affect, and plasma levels in depression Psychol Med 21 1991 599 611
9. Maas JW Koslow SH Davis J Katz MM Mendels J Robins E Stokes P Bowden CL Biological component of the NIMH Clinical Research Branch Collaborative Program on the Psychobiology of Depression I: Back-ground and theoretical consideration Psychol Med 10 1980 759 776
10. Montgomery SA Rapid onset of action of venlafaxine Int Clin Psychopharmacol 10 suppl 2 1995 21 27
11. Quitkin FM Rabkin JG Ross D Stewart JW Identification of true drug response to antidepressants: Use of pattern analysis Arch Gen Psychiatry 41 1984 259 264
12. Quitkin FM Rabkin JG Markowitz JM Stewart JW McGrath PJ Harrison W Use of pattern analysis to identify true drug response: A replication Arch Gen Psychiatry 44 1987 259 264
13. Rickels K Derivan A Entusah R Miska S Rudolph R Rapid onset of antidepressant activity with venlafaxine treatment Depression 3 1995 146 153
14. Small JG Milstein V Kellams JJ Small IF Comparative onset of improvement in depressive symptomatology with drug treatment, electroconvulsive therapy, and placebo J Clin Psychopharmacol 1 Suppl 6 1981 62 69
15. Smith WT Glaudin V Panagides J Gilvary E Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder Psychopharmacol Bull 26 1990 191 196
16. Stassen HH Delini-Stula A Angst J Time course of improvement under antidepressant treatment: A sur-vival-analytical approach Eur Neuropsychopharmacol 3 1993 127 135
17. Tollefson TG Holman SL How long to onset of anti-depressant action: A meta-analysis of patients treated with fluoxetine or placebo Int Clin Psychopharmacol 9 1994 245 250